VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
WSMNX
Price
$28.04
Change
+$0.09 (+0.32%)
Updated
Jun 22 closing price
Net Assets
1.31B
Interact to see
Advertisement

VMGMX vs WSMNX

VMGMX vs WSMNX Comparison Chart in %
View a ticker or compare two or three
VS
VMGMX vs. WSMNX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMGMX is a StrongBuy and WSMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. WSMNX (1.31B). VMGMX pays higher dividends than WSMNX: VMGMX (0.62) vs WSMNX (0.00). VMGMX was incepted earlier than WSMNX: VMGMX (15 years) vs WSMNX (23 years). WSMNX (1.37) is less costly to investors than VMGMX (0.07). WSMNX is a more actively managed with annual turnover of: 57.00 vs. VMGMX (17.00). WSMNX has a lower initial minimum investment than VMGMX: WSMNX (2500) vs VMGMX (3000). WSMNX annual gain was more profitable for investors over the last year : 22.21 vs. VMGMX (11.76). VMGMX return over 5 years is better than : 31.10 vs. WSMNX (-21.27).
VMGMXWSMNXVMGMX / WSMNX
Total Expense Ratio0.071.246%
Annual Report Gross Expense Ratio0.071.375%
Fund Existence15 years23 years-
Gain YTD9.95213.48074%
Front LoadN/AN/A-
Min. Initial Investment30002500120%
Min. Initial Investment IRAN/AN/A-
Net Assets33.8B1.31B2,580%
Annual Yield % from dividends0.620.00-
Returns for 1 year11.7622.2153%
Returns for 3 years55.538.50653%
Returns for 5 years31.10-21.27-146%
Returns for 10 years213.1352.82404%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4